- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Merz’s exhibition claim that Xeomin was “at least as effective as Botox” was ruled misleading because the cited…
A palliative medicine consultant complained about an Actiq rep’s comments on competitor Abstral. The Panel found misleading/disparaging competitor…
A health professional alleged a rep used delivery of an attendance certificate to secure a follow-up meeting (Clause…
At a Parkinson’s congress, an HCP symposium invite went into patient bags and a stand promoted “slowing clinical…
PMCPA case AUTH/3089/9/18 (Director v Merck Serono) concerned clinical trial disclosure. Under the 2016 ABPI Code it was…
Anonymous complaint alleged Roche pressured a hospital pharmacist to continue an RA project and provided drinks/money. Panel found…
Anonymous HCP alleged late-night hotel bar entertaining at ISTH Amsterdam. Panel accepted Bayer account of 4 drinks bought…
Ipsen’s Dysport leavepieces compared dose ratios vs other BoNT-A products using SPC data and a 2012 systematic review.…
Roche admitted a paid-for page in a consumer breast cancer magazine promoted Herceptin and Avastin to the public.…
Vifor’s Ferinject materials and briefings were found to encourage comparative safety messaging that disparaged Monofer and misled HCPs,…
One real case. One key lesson. Every week — free.